未登录

Z

Zhenling Guo

southern medical university - china

H指数:6

被引数:298

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The synergy of TPL and selinexor in MLL-R acute myeloid leukemia via Rap1/Raf/MEK pathway-mediated MYC downregulation

TPL与selinexor在MLL-R急性髓系白血病中的协同作用，通过Rap1/Raf/MEK通路介导的MYC下调

TRANSLATIONAL ONCOLOGY

IF4.1

2025-07-010

PRE

Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

FRONTIERS IN IMMUNOLOGY

IF5.9

2020-11-2737

OAAI

Mechanisms underlying CD19-positive ALL relapse after anti-CD19 CAR T cell therapy and associated strategies

anti-CD19 CAR T细胞治疗后CD19-positive ALL复发的潜在机制及相关策略

BIOMARKER RESEARCH

IF11.5

2020-05-2755

OAAI

CD19 and CD70 Dual-Target Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Relapsed and Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma

FRONTIERS IN ONCOLOGY

IF3.3

2019-12-0460

OAAI

Shortening the ex vivo culture of CD19-specific CAR T-cells retains potent efficacy against acute lymphoblastic leukemia without CAR T-cell-related encephalopathy syndrome or severe cytokine release syndrome

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2019-10-0216

OAAI